Infliximab induction regimens in steroid-refractory acute severe colitis: a multicentre retrospective cohort study with propensity score analysis.
Shaji SebastianSally MyersKonstantinos ArgyriouGayle MartinLouis LosJoseph FiskeRavi RanjanBenjamin CooperVivek GoodooryHey-Long ChingNishaniLalanthika JayasooriyaJohanne BrooksAnjan DharAchut H ShenoyJimmy K LimdiJeffrey ButterworthPatrick B AllenSunil SamuelGordon William MoranRichard ShendereyGareth ParkesAlan LoboNicholas A KennedySreedhar SubramanianTim RainePublished in: Alimentary pharmacology & therapeutics (2020)
In a propensity score-matched cohort, steroid-refractory acute severe ulcerative colitis patients, short-term, but not long-term, colectomy rates appear to be lower in those receiving an accelerated induction regimen.
Keyphrases
- ulcerative colitis
- liver failure
- drug induced
- end stage renal disease
- respiratory failure
- ejection fraction
- newly diagnosed
- early onset
- chronic kidney disease
- clinical trial
- aortic dissection
- prognostic factors
- peritoneal dialysis
- hepatitis b virus
- cross sectional
- intensive care unit
- acute respiratory distress syndrome
- mechanical ventilation